Unexplained Stillbirth Clinical Trial
Official title:
Second Generation Low Molecular Weight Heparin (Bemiparin) as a Prophylactic for Management of Subsequent Pregnancy After an Unexplained Stillbirth: A Clinical Comparative Study
Bemiparin for pregnant women with abnormal umbilical artery Doppler ultrasound
152 women with history of unexplained stillbirths were identified , umbilical arty Doppler
ultrasound was conducted for them at 20-22 weeks gestation . they were divided into two group
, group one are those with abnormal resistant index (= or more than 0.6) thy received
Bemiparin 2500 IU subcutaneously daily up to 24 hours before delivery .
Group 2 with normal umbilical artery resistant index received no any interventions just
routine antenatal follow up .
;